AxoGen Inc
NASDAQ:AXGN
Operating Margin
AxoGen Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
|
AxoGen Inc
NASDAQ:AXGN
|
718.3m USD |
-2%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
226.4B USD |
17%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
183.7B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
151.7B USD |
19%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
142.6B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.8B USD |
19%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
53B EUR |
13%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
60.1B USD |
14%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.4B USD |
28%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
266.3B CNY |
36%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
35.3B USD |
29%
|
AxoGen Inc
Glance View
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. The company is headquartered in Alachua, Florida and currently employs 428 full-time employees. Its platform for peripheral nerve repair features a comprehensive portfolio of products, including Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Avive Soft Tissue Membrane and Axotouch Two-Point Discriminator. Its products are used by surgeons during surgical interventions to repair a variety of physical nerve damage or transection throughout the body, which ranges from a simple laceration of a finger to a complex brachial plexus injury, as well as nerve injuries caused by dental, orthopedic, and other surgical procedures. Its Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Its portfolio of products is available in the United States, Canada, Germany, Spain, South Korea, and several other countries.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on AxoGen Inc's most recent financial statements, the company has Operating Margin of -1.8%.
You don't have any saved screeners yet